 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
AMARIN CORP PLC A, (AMRN) Stock Rating Learn More
| Our Overall Rating on AMARIN CORP PLC A, AMRN is Not Available | | Amarin Corporation plc, a neuroscience pharmaceutical company, engages in the development and commercialization of novel drugs for the treatment of neurological disorders affecting the central nervous system. The companys principal compound, Miraxion, is in phase III development for Huntington's disease. It also develops Miraxion for the treatment of other central nervous system disorders, including treatment unresponsive depression. The company, formerly known as Ethical Holdings plc, was incorporated in 1989 and is headquartered in London. | | Our Not Available Rating on AMRN was issued on 11/22/2008 |
AMARIN CORP PLC A Technical Rating
|
|
|
|
